Copyright
©The Author(s) 2024.
World J Clin Cases. Sep 26, 2024; 12(27): 6057-6069
Published online Sep 26, 2024. doi: 10.12998/wjcc.v12.i27.6057
Published online Sep 26, 2024. doi: 10.12998/wjcc.v12.i27.6057
Parameter | Crude OR (95%CI) | P value |
Age in yr | ||
≥ 55 | 0.546 (0.222, 1.343) | 0.188 |
< 55 | 1.000 | |
Sex | ||
Female | 0.662 (0.261, 1.681) | 0.386 |
Male | 1.000 | |
Previous systemic therapy | ||
Any | 1.603 (0.574, 4.482) | 0.368 |
Never | 1.000 | |
Clinical presentation | ||
Primary | 1.210 (0.500, 2.931) | 0.673 |
Recurrence | 1.000 | |
Cancer type | ||
Ovary | 0.646 (0.239, 1.746) | 0.389 |
GI | 1.000 | |
CC score | ||
0 | 0.141 (0.037, 0.541) | 0.004a |
1 | 1.000 | |
PCI score | ||
1-7 | 0.444 (0.180, 1.095) | 0.078 |
8-39 | 1.000 | |
HIPEC regimen | ||
Cisplatin | 1.778 (0.657, 4.809) | 0.257 |
Non-cisplatin | 1.000 | |
HIPEC duration in min | ||
≤ 60 | 1.565 (0.632, 3.879) | 0.333 |
90 | 1.000 | |
Extraperitoneal oligometastasis | ||
Any | 1.071 (0.401, 2.830) | 0.890 |
None | 1.000 | |
Surgical method | ||
Laparoscopy | 0.858 (0.239, 3.077) | 0.814 |
Laparotomy | 1.000 | |
Histology grade | ||
Grade 1/2 | 0.656 (0.270, 1.597) | 0.353 |
Grade 3 | 1.000 | |
Pre-HIPEC chemotherapy1 | ||
Yes | 2.259 (0.922, 5.532) | 0.075 |
No | 1.000 | |
Post-HIPEC chemotherapy2 | ||
Yes | 1.500 (0.389, 5.781) | 0.556 |
No | 1.000 | |
CRS time in h | ||
≤ 6 | 0.361 (0.146, 0.892) | 0.027a |
> 6 | 1.000 | |
Bowel resection | ||
Yes | 2.143 (0.858, 5.351) | 0.103 |
No | 1.000 |
- Citation: Chen CY, Huang TH, Lee LW, Lung J, Ou YC, Hung CH, Chuang HC, Chen MC, Wang TY. Prognostic factors of early recurrence after complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Clin Cases 2024; 12(27): 6057-6069
- URL: https://www.wjgnet.com/2307-8960/full/v12/i27/6057.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i27.6057